Cargando…
Nationwide system to centralize decisions around ECMO use for severe COVID-19 pneumonia in Japan (Special Correspondence)
The novel coronavirus disease 2019 (COVID-19) is spreading in Japan. We have collected a total of 26 patients with COVID-19 who required extracorporeal membranous oxygenation (ECMO). The available data from the first 14 cases demonstrated that the median age of patients was 71 and the median PaO(2)/...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180634/ https://www.ncbi.nlm.nih.gov/pubmed/32341785 http://dx.doi.org/10.1186/s40560-020-00445-4 |
Ejemplares similares
-
Correction to: Nationwide system to centralize decisions around ECMO use for severe COVID-19 pneumonia in Japan (Special Correspondence)
Publicado: (2020) -
Nationwide system to centralize decisions around extracorporeal membranous oxygenation use for severe COVID‐19 pneumonia in Japan
por: Takeda, Shinhiro
Publicado: (2020) -
Correspondence on artificial intelligence algorithm for COVID-19 pneumonia
por: Sookaromdee, Pathum, et al.
Publicado: (2022) -
Regional referral ECMO centre decision and mid-term mortality of patients suffering severe Acute Respiratory Distress Syndrome (ARDS)
por: Rozé, Hadrien, et al.
Publicado: (2020) -
What is New in ECMO for COVID-19?
por: Furzan, Alberto, et al.
Publicado: (2023)